Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/89026
Title: | Serum cystatin C and Coronavirus disease 2019 : a potential inflammatory biomarker in predicting critical illness and mortality for adult patients | Authors: | Chen, D Sun, W Li, J Wei, B Liu, W Wang, X Song, F Chen, L Yang, J Yu, L |
Issue Date: | Dec-2020 | Source: | Mediators of inflammation, 2020, v. 2020, 3764515, p. 1-10 | Abstract: | This study aimed at determining the relationship between baseline cystatin C levels and coronavirus disease 2019 (COVID-19) and investigating the potential prognostic value of serum cystatin C in adult patients with COVID-19. 481 patients with COVID-19 were consecutively included in this study from January 2, 2020, and followed up to April 15, 2020. All clinical and laboratory data of COVID-19 patients with definite outcomes were reviewed. For every measure, COVID-19 patients were grouped into quartiles according to the baseline levels of serum cystatin C. The highest cystatin C level was significantly related to more severe inflammatory conditions, worse organ dysfunction, and worse outcomes among patients with COVID-19 (P values < 0.05). In the adjusted logistic regression analyses, the highest cystatin C level and ln-transformed cystatin C levels were independently associated with the risks of developing critically ill COVID-19 and all-cause death either in overall patients or in patients without chronic kidney disease (P values < 0.05). As a potential inflammatory marker, increasing baseline levels of serum cystatin C might independently predict adverse outcomes for COVID-19 patients. Serum cystatin C could be routinely monitored during hospitalization, which showed clinical importance in prognosticating for adult patients with COVID-19. Copyright © 2020 Dan Chen et al. | Publisher: | Hindawi | Journal: | Mediators of inflammation | ISSN: | 0962-9351 | EISSN: | 1466-1861 | DOI: | 10.1155/2020/3764515 | Rights: | Copyright © 2020 Dan Chen et al. This is an open access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The following publication Chen, D., Sun, W., Li, J., Wei, B., Liu, W., Wang, X., . . . Yu, L. (2020). Serum Cystatin C and Coronavirus Disease 2019: A Potential Inflammatory Biomarker in Predicting Critical Illness and Mortality for Adult Patients. Mediators of Inflammation, 2020, 3764515. doi:10.1155/2020/3764515 is available at https://dx.doi.org/10.1155/2020/3764515 |
Appears in Collections: | Journal/Magazine Article |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Chen_Serum_Cystatin_C.pdf | 730.81 kB | Adobe PDF | View/Open |
Page views
55
Last Week
0
0
Last month
Citations as of Apr 21, 2024
Downloads
18
Citations as of Apr 21, 2024
SCOPUSTM
Citations
14
Citations as of Apr 4, 2024
WEB OF SCIENCETM
Citations
14
Citations as of Apr 18, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.